Invasive non-typhoidal Salmonella Emerges as a Persistent Bloodstream Threat in Ghana
Invasive non-typhoidal Salmonella disease is carrying a heavier clinical load in Ghana than many frontline clinicians may appreciate. Across eight years of fever surveillance, the organism accounted for 15.5% of all blood-culture-derived bacterial pathogens, making it the second most common cause of bacteremia in the cohort.
The signal is clinically important because invasive disease behaves very differently from the diarrheal illness most people associate with Salmonella. Here, the bacteria crossed the gut barrier and entered the bloodstream, where the presentation can look like many other febrile syndromes and can be missed without culture-based testing. In regions where blood cultures are not routine, that diagnostic blind spot becomes a treatment problem as much as a surveillance problem.
Fever Surveillance Across Urban and Rural Ghana Captured the Burden
The study drew on fever surveillance in Ghana from May 2016 through December 2023, spanning both the SETA and SETA PLUS programs. Four hospitals in the Ashanti Region contributed cases: Komfo Anokye Teaching Hospital and Maternal and Child Health Hospital in Kumasi, plus Agogo Presbyterian Hospital and Konongo Government Hospital in rural districts. This mix matters because iNTS burden can shift with geography, access to care, and local transmission patterns.
Enrollment targeted patients with current fever or a history of fever lasting at least three consecutive days in the week before presentation. Blood samples were processed quickly, with culture performed in the BACTEC system and downstream identification using standard biochemical testing, serogrouping, and whole-genome sequencing confirmation. That laboratory pathway gave the analysis a level of microbiologic precision that is rarely available in routine care settings.
Seasonal clustering was evident. Peak detections lined up with Ghana’s rainy seasons, reinforcing a recurring pattern seen in sub-Saharan Africa where rainfall appears to track with bloodstream Salmonella transmission. The biological explanation is plausible even if the precise mechanism is not pinned down here: heavy rains can reshape sanitation, water exposure, and environmental contamination, increasing opportunities for enteric pathogens to spread and invade vulnerable hosts.
Anaemia Stood Out as the Independent Clinical Predictor
Several clinical and laboratory features appeared associated with iNTS in crude comparisons, but most lost significance after adjustment. Anaemia remained the only factor with an independent association, with an adjusted odds ratio of 2.41 and a p value of 0.030.
That finding is clinically familiar in malaria-endemic settings, where anaemia often signals a fragile host state rather than a single diagnosis. Reduced haemoglobin reserve can reflect malnutrition, repeated infection, hemolysis, or chronic inflammatory stress, and each of those conditions can weaken host defence against invasive bacterial disease. In practical terms, an anaemic child with prolonged fever in this setting should not be managed as routine febrile illness until bacteremia has been considered and excluded.
The burden was heaviest in children under 5 years of age. In that age band, immature immunity, frequent exposure to contaminated environments, and overlapping infections create an especially permissive environment for invasive disease. The study’s findings fit that pattern closely, with the youngest children carrying the greatest burden.
Multidrug Resistance Is Moving Into Critical Treatment Territory
Antimicrobial resistance added another layer of concern. Among the iNTS isolates, 23.7% were multidrug-resistant, and 5.3% were extensively drug-resistant. The resistant strains included organisms resistant to ceftriaxone and ciprofloxacin, two agents that often sit near the center of empiric management decisions for serious bacterial infection.
Resistance to those drugs narrows bedside options quickly. Ceftriaxone is widely used because of its utility in invasive enteric fever and other severe community-acquired infections, while ciprofloxacin remains important in many treatment algorithms where susceptibility is expected. Once resistance reaches both classes, clinicians are pushed toward less convenient and potentially more expensive alternatives, often without the benefit of rapid susceptibility data.
This is not an abstract stewardship issue. It is a direct threat to timely effective therapy in febrile children and adults whose infection may already be advanced by the time they reach care.
Culture Confirmation Still Defines the Diagnosis
Diagnosis in this setting remains anchored to microbiologic culture. Blood culture is the standard route to confirming iNTS disease, yet sensitivity is limited and no rapid diagnostic test is available for routine use. Commercial antibody tests and the obsolete Widal test do not solve the problem for invasive non-typhoidal disease.
That leaves clinicians with a frustrating gap: the syndrome is common, the presentation is nonspecific, and the confirmatory test is not universally available. Fever alone does not distinguish iNTS from malaria, typhoid, viral illness, or other bacterial bloodstream infections. In routine practice, that diagnostic overlap can delay treatment or lead to empiric therapy that misses resistant organisms.
The surveillance approach used here shows why microbiology capacity matters. Without blood culture, iNTS remains invisible in many febrile patients, and public health estimates will continue to understate the true burden.
Why These Findings Matter for Frontline Care
The clinical message is straightforward. In Ghana, invasive non-typhoidal Salmonella should be treated as a major cause of bloodstream infection, especially in young children and in patients with anaemia. Rainy-season clustering suggests that environmental exposure and transmission dynamics are not random, and clinicians working during those months should keep a lower threshold for culture-based evaluation.
The resistance profile sharpens the concern further. When a quarter of isolates are multidrug-resistant and a smaller but consequential fraction are extensively drug-resistant, empiric therapy becomes less dependable. Empiric choices need local susceptibility data, and local susceptibility data require sustained surveillance.
This study helps close an important knowledge gap for Ghana and the wider West African region, but it also leaves a hard clinical task in place: making culture-based diagnosis and resistance monitoring available often enough to change treatment in real time. Without that, the most vulnerable patients will continue to present with an illness that is severe, nonspecific, and increasingly difficult to treat.